Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Whales with a lot of money to spend have taken a noticeably bearish stance on DexCom.
Looking at options history for DexCom (NASDAQ:DXCM) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 47% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $680,373 and 8, calls, for a total amount of $608,895.
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $45.0 to $110.0 for DexCom over the recent three months.
In terms of liquidity and interest, the mean open interest for DexCom options trades today is 694.29 with a total volume of 2,476.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for DexCom's big money trades within a strike price range of $45.0 to $110.0 over the last 30 days.
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
DXCM | PUT | SWEEP | BULLISH | 06/20/25 | $12.2 | $11.8 | $12.2 | $70.00 | $245.2K | 32 | 201 |
DXCM | PUT | TRADE | BEARISH | 06/20/25 | $2.8 | $1.8 | $2.7 | $45.00 | $189.0K | 63 | 700 |
DXCM | CALL | TRADE | BEARISH | 09/20/24 | $19.5 | $16.6 | $17.5 | $50.00 | $105.0K | 7 | 120 |
DXCM | CALL | SWEEP | BEARISH | 01/17/25 | $10.3 | $10.0 | $10.0 | $65.00 | $100.0K | 1.0K | 40 |
DXCM | CALL | TRADE | BULLISH | 09/20/24 | $17.8 | $13.1 | $16.0 | $50.00 | $96.0K | 7 | 0 |
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
In the last month, 5 experts released ratings on this stock with an average target price of $104.0.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for DexCom, Benzinga Pro gives you real-time options trades alerts.
Posted In: DXCM